CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Booster Therapeutics
Germany
- Berlin
- 11/10/2024
- Seed
- $15,000,000
Booster Therapeutics is pioneering a new class of medicines that activate proteasomes (the cell’s natural quality control machinery) to treat a range of complex indications. The company is developing a multi-disease pipeline, with an initial focus on neurodegenerative diseases associated with impaired proteasome function.
- Industry Biotechnology Research
- Website https://www.boostertx.com/
- LinkedIn https://www.linkedin.com/company/booster-therapeutics/
Related People
Diogo R. FelecianoCo Founder
Germany -
Berlin, Berlin
My mission is to revolutionize patient health by spearheading the development of game-changing and innovative treatments.
In 2020, founded Booster Therapeutics with the aim of discovering and developing a new class of drugs that can potentially treat various diseases where conventional treatment options fall short.
With over a decade of expertise in life sciences acquired through academic research, venture capital, and biotech, I have specialized knowledge in R&D, company building, and aging/neuro/ocular biology.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)